Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases

Receptor tyrosine kinases (RTK) have been the most prevalent therapeutic targets in anti-cancer drug development. However, the emergence of drug resistance toward single target RTK inhibitors remains a major challenge to achieve long-term remissions. Development of alternative RTK inhibitory strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kaidi, Wang, Xuan, Hou, Yiying, Zhou, Huihui, Mai, Kangsen, He, Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588694/
https://www.ncbi.nlm.nih.gov/pubmed/31263775
http://dx.doi.org/10.1038/s42003-019-0484-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588694/
https://www.ncbi.nlm.nih.gov/pubmed/31263775
http://dx.doi.org/10.1038/s42003-019-0484-5

Ejemplares similares